Mesayamas Kongsema
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Mesayamas Kongsema has a total of 77 co-authors. Here are the top co-authors by number of shared publications:
- Eric Wing-Fai Lam
Department of Surgery and Cancer, Imperial College London, London, W12 0NN, UK
4 shared publications - Pasarat Khongkow
Department of Biomedical Sciences and Biomedical Engineering, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand
4 shared publications A R Gomes
Department of Surgery and Cancer, Imperial College London, Imperial Centre for Translational and Experimental Medicine (ICTEM), London, UK
3 shared publications- Mattaka Khongkow
National Nanotechnology Centre (NANOTEC), National Science and Technology Development Agency, Pathum Thani 12120, Thailand
3 shared publications Eric W.-F. Lam
Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital Campus, London W12 0NN, UK
2 shared publicationsKantimanee Pradermwong
Department of Zoology Faculty of Science Kasetsart University Bangkok Thailand
2 shared publications
Latest Publications
- Open Access
- 1 January 2022
- Published by Office of Academic Resources, Chulalongkorn University - DIGITAL COMMONS JOURNALS in The Thai Journal of Pharmaceutical Sciences
- Vol. 46 (1) , 28-36
Cytotoxic effect of crude Vitex glabrata fruit extracts on human cancer cell lines
Vitex glabrata (VG) or Khai-noa fruit extracts were prepared from three methods; squeezing extract (SE), maceration extract (ME), and ethanol extraction (EE) to evaluate their effects in vitro. By the (1,1-diphenyl-2-picrylhydrazyl) scavenging assay, all extracts revealed very weak antioxidant. Results of (3-(4, 5-Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide, a tetrazole) assay showed the increase in cell viability of SE at 100 and 500 μg/ml on TK6 cells after 24 and 48 h treatments (P < 0.01) without affecting Caco-2 cells. Conversely, a dose- and time-dependent cytotoxicity of all extracts revealed at 1000-2000 μg/ml on both cells (P < 0.01). SE showed cytotoxicity on PC-3 cells and anticancer activity when confirmed by clonogenic assay in a dose-dependent manner. SE also showed cytotoxicity on HT-29 cells after 24 h treatment but the cells could recurrent in the clonogenic assay. No effect was observed on MCF-7 cells after SE alone, SE co-treated with MMC treatment, and in the clonogenic assay. Moreover, HT-29 cells revealed a dose-dependent decrease in viability when treated with SE co-treated with MMC by 24 h. Hence, SE can selectively promote cell viability on TK6 and anticancer activity on PC-3. These results suggest that the different potential of SE depends on different cell lines.
- 1 January 2022
- Published by Office of Academic Resources, Chulalongkorn University - DIGITAL COMMONS JOURNALS in The Thai Journal of Pharmaceutical Sciences
- Vol. 46 (1) , 28-36
Open AccessCytotoxic effect of crude Vitex glabrata fruit extracts on human cancer cell lines
Vitex glabrata (VG) or Khai-noa fruit extracts were prepared from three methods; squeezing extract (SE), maceration extract (ME), and ethanol extraction (EE) to evaluate their effects in vitro. By the (1,1-diphenyl-2-picrylhydrazyl) scavenging assay, all extracts revealed very weak antioxidant. Results of (3-(4, 5-Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide, a tetrazole) assay showed the increase in cell viability of SE at 100 and 500 μg/ml on TK6 cells after 24 and 48 h treatments (P < 0.01) without affecting Caco-2 cells. Conversely, a dose- and time-dependent cytotoxicity of all extracts revealed at 1000-2000 μg/ml on both cells (P < 0.01). SE showed cytotoxicity on PC-3 cells and anticancer activity when confirmed by clonogenic assay in a dose-dependent manner. SE also showed cytotoxicity on HT-29 cells after 24 h treatment but the cells could recurrent in the clonogenic assay. No effect was observed on MCF-7 cells after SE alone, SE co-treated with MMC treatment, and in the clonogenic assay. Moreover, HT-29 cells revealed a dose-dependent decrease in viability when treated with SE co-treated with MMC by 24 h. Hence, SE can selectively promote cell viability on TK6 and anticancer activity on PC-3. These results suggest that the different potential of SE depends on different cell lines.
- 1 June 2021
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 110 (6) , 2508-2516
Liposomal Thiostrepton Formulation and Its Effect on Breast Cancer Growth Inhibition
- 1 June 2021
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 110 (6) , 2508-2516
Liposomal Thiostrepton Formulation and Its Effect on Breast Cancer Growth Inhibition
- Open Access
- 1 January 2020
- Published by Office of Academic Resources, Chulalongkorn University - DIGITAL COMMONS JOURNALS in The Thai Journal of Pharmaceutical Sciences
- Vol. 44 (4) , 220-228
Cell viability enhancing and cellular protection activity of Vitex glabrata R.Br. crude fruits extract on TK6 and L929 cell lines
Studying the plant-based traditional medicine is a starting point for the advancement of modern studies. Vitex glabrata (VG) or Khai-Noa is a medicinal plant in Thailand, which fruits have been used by Thai ancients to improve cognition and enhance memor.
- 1 January 2020
- Published by Office of Academic Resources, Chulalongkorn University - DIGITAL COMMONS JOURNALS in The Thai Journal of Pharmaceutical Sciences
- Vol. 44 (4) , 220-228
Open AccessCell viability enhancing and cellular protection activity of Vitex glabrata R.Br. crude fruits extract on TK6 and L929 cell lines
Studying the plant-based traditional medicine is a starting point for the advancement of modern studies. Vitex glabrata (VG) or Khai-Noa is a medicinal plant in Thailand, which fruits have been used by Thai ancients to improve cognition and enhance memor.
- 1 October 2019
- Published by Elsevier in Materials Science and Engineering: C
- Vol. 103, 109829
Biocompatibility and biodegradability of filler encapsulated chloroacetated natural rubber/polyvinyl alcohol nanofiber for wound dressing
- 1 October 2019
- Published by Elsevier in Materials Science and Engineering: C
- Vol. 103, 109829
Biocompatibility and biodegradability of filler encapsulated chloroacetated natural rubber/polyvinyl alcohol nanofiber for wound dressing
- Open Access
- 1 September 2019
- Published by IOP Publishing in IOP Conference Series: Materials Science and Engineering
- Vol. 625 (1) , 012024
Synthesis of calcium phosphate composite organogels by using castor oil and sorbitan monopalmitate based for dentine occlusion material
Calcium phosphate composite organogel was synthesized from a mixture of sorbitan monopalmitate as emulsifier and castor oil as oil phase at 60 °C to establish emulsion system with calcium chloride and di-sodium hydrogen phosphate aqueous solution as water phase. The heated mixture was cooled at room temperature to form organogel. The prepared organogels were investigated by thermogravimetric analysis (TGA), scanning electron microscope (SEM), transmission electron microscope (TEM) and cytotoxicity test. The prepared organogels of 4:3 and 1:1 in oil/water content ratio were white and gritty in nature, which resulted in calcium phosphate nanoparticles with spherical shape of 1.3 to 1.9 μm and 1.2 to 2.3 μm, respectively. They were able to successfully occlude into dentine tubules within 1 day. In addition, the prepared organogels were found to have acceptable toxicity level for daily human use with high concentration up to 1600 μg/ml. Hence, these organogels showed the promising results to be developed as an effective dentine occlusion material in relieving of dentin hypersensitivity.
- 1 September 2019
- Published by IOP Publishing in IOP Conference Series: Materials Science and Engineering
- Vol. 625 (1) , 012024
Open AccessSynthesis of calcium phosphate composite organogels by using castor oil and sorbitan monopalmitate based for dentine occlusion material
Calcium phosphate composite organogel was synthesized from a mixture of sorbitan monopalmitate as emulsifier and castor oil as oil phase at 60 °C to establish emulsion system with calcium chloride and di-sodium hydrogen phosphate aqueous solution as water phase. The heated mixture was cooled at room temperature to form organogel. The prepared organogels were investigated by thermogravimetric analysis (TGA), scanning electron microscope (SEM), transmission electron microscope (TEM) and cytotoxicity test. The prepared organogels of 4:3 and 1:1 in oil/water content ratio were white and gritty in nature, which resulted in calcium phosphate nanoparticles with spherical shape of 1.3 to 1.9 μm and 1.2 to 2.3 μm, respectively. They were able to successfully occlude into dentine tubules within 1 day. In addition, the prepared organogels were found to have acceptable toxicity level for daily human use with high concentration up to 1600 μg/ml. Hence, these organogels showed the promising results to be developed as an effective dentine occlusion material in relieving of dentin hypersensitivity.
- Open Access
- 8 July 2019
- Published by Spandidos Publications in Oncology Reports
- Vol. 42 (3) , 953-962
Molecular mechanism of Forkhead box M1 inhibition by thiostrepton in breast cancer cells
Breast cancer is the most common type of malignancies in women worldwide, and genotoxic chemotherapeutic drugs are effective by causing DNA damage in cancer cells. However, >90% of patients with metastatic cancer are resistant to chemotherapy. The Forkhead box M1 (FOXM1) transcription factor plays a pivotal role in the resistance of breast cancer cells to chemotherapy by promoting DNA damage repair following genotoxic drug treatment. The aim of the present study was to investigate the inhibition of the FOXM1 protein by thiostrepton, a natural antibiotic produced by the Streptomyces species. Experimental studies were designed to examine the effectiveness of thiostrepton in downregulating FOXM1 mRNA expression and activity, leading to senescence and apoptosis of breast cancer cells. The cytotoxicity of thiostrepton in breast cancer was determined using cell viability assay. Additionally, thiostrepton treatment decreased the mRNA expression of cyclin B1 (CCNB1), a downstream target of FOXM1. The present results indicated that thiostrepton inhibited FOXM1 mRNA expression and its effect on CCNB1. Molecular dynamic simulations were performed to study the interactions between FOXM1‑DNA and thiostrepton after molecular docking. The results revealed that the possible mechanism underlying the inhibitory effect of thiostrepton on FOXM1 function was by forming a tight complex with the DNA and FOXM1 via its binding domain. Collectively, these results indicated that thiostrepton is a specific and direct inhibitor of the FOXM1 protein in breast cancer. The findings of the present study may lead to the development of novel therapeutic strategies for breast cancer and help overcome resistance to conventional chemotherapeutic drugs.
- 8 July 2019
- Published by Spandidos Publications in Oncology Reports
- Vol. 42 (3) , 953-962
Open AccessMolecular mechanism of Forkhead box M1 inhibition by thiostrepton in breast cancer cells
Breast cancer is the most common type of malignancies in women worldwide, and genotoxic chemotherapeutic drugs are effective by causing DNA damage in cancer cells. However, >90% of patients with metastatic cancer are resistant to chemotherapy. The Forkhead box M1 (FOXM1) transcription factor plays a pivotal role in the resistance of breast cancer cells to chemotherapy by promoting DNA damage repair following genotoxic drug treatment. The aim of the present study was to investigate the inhibition of the FOXM1 protein by thiostrepton, a natural antibiotic produced by the Streptomyces species. Experimental studies were designed to examine the effectiveness of thiostrepton in downregulating FOXM1 mRNA expression and activity, leading to senescence and apoptosis of breast cancer cells. The cytotoxicity of thiostrepton in breast cancer was determined using cell viability assay. Additionally, thiostrepton treatment decreased the mRNA expression of cyclin B1 (CCNB1), a downstream target of FOXM1. The present results indicated that thiostrepton inhibited FOXM1 mRNA expression and its effect on CCNB1. Molecular dynamic simulations were performed to study the interactions between FOXM1‑DNA and thiostrepton after molecular docking. The results revealed that the possible mechanism underlying the inhibitory effect of thiostrepton on FOXM1 function was by forming a tight complex with the DNA and FOXM1 via its binding domain. Collectively, these results indicated that thiostrepton is a specific and direct inhibitor of the FOXM1 protein in breast cancer. The findings of the present study may lead to the development of novel therapeutic strategies for breast cancer and help overcome resistance to conventional chemotherapeutic drugs.
- Open Access
- 25 February 2016
- Published by Springer Nature
- Vol. 1395, 39-53
In Vitro Methods for Studying the Mechanisms of Resistance to DNA-Damaging Therapeutic Drugs
Most commonly used anticancer drugs exert their effects mainly by causing DNA damage. The enhancement in DNA damage response (DDR) is considered a key mechanism that enables cancer cells to survive through eliminating the damaged DNA lesions and thereby developing resistance to DNA-damaging agents. This chapter describes the four experimental approaches for studying DDR and genotoxic drug resistance, including the use of γ-H2AX and comet assays to monitor DNA damage and repair capacity as well as the use of clonogenic and β-galactosidase staining assays to assess long-term cell fate after DNA-damaging treatment. Finally, we also present examples of these methods currently used in our laboratory for studying the role of FOXM1 in DNA damage-induced senescence and epirubicin resistance.
- 25 February 2016
- Published by Springer Nature
- Vol. 1395, 39-53
Open AccessIn Vitro Methods for Studying the Mechanisms of Resistance to DNA-Damaging Therapeutic Drugs
Most commonly used anticancer drugs exert their effects mainly by causing DNA damage. The enhancement in DNA damage response (DDR) is considered a key mechanism that enables cancer cells to survive through eliminating the damaged DNA lesions and thereby developing resistance to DNA-damaging agents. This chapter describes the four experimental approaches for studying DDR and genotoxic drug resistance, including the use of γ-H2AX and comet assays to monitor DNA damage and repair capacity as well as the use of clonogenic and β-galactosidase staining assays to assess long-term cell fate after DNA-damaging treatment. Finally, we also present examples of these methods currently used in our laboratory for studying the role of FOXM1 in DNA damage-induced senescence and epirubicin resistance.
- 1 May 2015
- Published by Royal Society of Chemistry (RSC) in Analytical Methods
- Vol. 7 (10) , 4071-4089
Automated multiwell fluorescence lifetime imaging for Förster resonance energy transfer assays and high content analysis
Fluorescence lifetime measurements can provide quantitative assays of the local fluorophore environment and can be applied to read out biomolecular interactions via Förster resonance energy transfer (FRET). Fluorescence lifetime imaging (FLIM) can be automated for high content analysis (HCA) to map protein–protein interactions with applications in drug discovery, systems biology and basic research. The automated acquisition of FLIM data over 100's of fields of view provides statistical power to overcome noise in instrumentation and biological systems and thus exploit relatively small changes in mean lifetime to provide useful readouts that would not be practically achievable in manual microscopy experiments. We present here an automated HCA system with the ability to perform rapid unsupervised optically sectioned FLIM of fixed and live biological samples and illustrate its potential through exemplar applications of different FRET readouts.
- 1 May 2015
- Published by Royal Society of Chemistry (RSC) in Analytical Methods
- Vol. 7 (10) , 4071-4089
Automated multiwell fluorescence lifetime imaging for Förster resonance energy transfer assays and high content analysis
Fluorescence lifetime measurements can provide quantitative assays of the local fluorophore environment and can be applied to read out biomolecular interactions via Förster resonance energy transfer (FRET). Fluorescence lifetime imaging (FLIM) can be automated for high content analysis (HCA) to map protein–protein interactions with applications in drug discovery, systems biology and basic research. The automated acquisition of FLIM data over 100's of fields of view provides statistical power to overcome noise in instrumentation and biological systems and thus exploit relatively small changes in mean lifetime to provide useful readouts that would not be practically achievable in manual microscopy experiments. We present here an automated HCA system with the ability to perform rapid unsupervised optically sectioned FLIM of fixed and live biological samples and illustrate its potential through exemplar applications of different FRET readouts.
- Open Access
- 23 December 2013
- Published by Springer Nature in Oncogene
- Vol. 33 (34) , 4316-4329
SUMOylation inhibits FOXM1 activity and delays mitotic transition
The forkhead box transcription factor FOXM1 is an essential effector of G2/M-phase transition, mitosis and the DNA damage response. As such, it is frequently deregulated during tumorigenesis. Here we report that FOXM1 is dynamically modified by SUMO1 but not by SUMO2/3 at multiple sites. We show that FOXM1 SUMOylation is enhanced in MCF-7 breast cancer cells in response to treatment with epirubicin and mitotic inhibitors. Mutation of five consensus conjugation motifs yielded a SUMOylation-deficient mutant FOXM1. Conversely, fusion of the E2 ligase Ubc9 to FOXM1 generated an auto-SUMOylating mutant (FOXM1-Ubc9). Analysis of wild-type FOXM1 and mutants revealed that SUMOylation inhibits FOXM1 activity, promotes translocation to the cytoplasm and enhances APC/Cdh1-mediated ubiquitination and degradation. Further, expression of the SUMOylation-deficient mutant enhanced cell proliferation compared with wild-type FOXM1, whereas the FOXM1-Ubc9 fusion protein resulted in persistent cyclin B1 expression and slowed the time from mitotic entry to exit. In summary, our findings suggest that SUMOylation attenuates FOXM1 activity and causes mitotic delay in cytotoxic drug response.
- 23 December 2013
- Published by Springer Nature in Oncogene
- Vol. 33 (34) , 4316-4329
Open AccessSUMOylation inhibits FOXM1 activity and delays mitotic transition
The forkhead box transcription factor FOXM1 is an essential effector of G2/M-phase transition, mitosis and the DNA damage response. As such, it is frequently deregulated during tumorigenesis. Here we report that FOXM1 is dynamically modified by SUMO1 but not by SUMO2/3 at multiple sites. We show that FOXM1 SUMOylation is enhanced in MCF-7 breast cancer cells in response to treatment with epirubicin and mitotic inhibitors. Mutation of five consensus conjugation motifs yielded a SUMOylation-deficient mutant FOXM1. Conversely, fusion of the E2 ligase Ubc9 to FOXM1 generated an auto-SUMOylating mutant (FOXM1-Ubc9). Analysis of wild-type FOXM1 and mutants revealed that SUMOylation inhibits FOXM1 activity, promotes translocation to the cytoplasm and enhances APC/Cdh1-mediated ubiquitination and degradation. Further, expression of the SUMOylation-deficient mutant enhanced cell proliferation compared with wild-type FOXM1, whereas the FOXM1-Ubc9 fusion protein resulted in persistent cyclin B1 expression and slowed the time from mitotic entry to exit. In summary, our findings suggest that SUMOylation attenuates FOXM1 activity and causes mitotic delay in cytotoxic drug response.
- Open Access
- 21 October 2013
- Published by Springer Nature in Oncogene
- Vol. 33 (32) , 4144-4155
FOXM1 targets NBS1 to regulate DNA damage-induced senescence and epirubicin resistance
FOXM1 is implicated in genotoxic drug resistance but its mechanism of action remains elusive. We show here that FOXM1-depletion can sensitize breast cancer cells and mouse embryonic fibroblasts (MEFs) into entering epirubicin-induced senescence, with the loss of long-term cell proliferation ability, the accumulation of γH2AX foci, and the induction of senescence-associated β-galactosidase activity and cell morphology. Conversely, reconstitution of FOXM1 in FOXM1-deficient MEFs alleviates the accumulation of senescence-associated γH2AX foci. We also demonstrate that FOXM1 regulates NBS1 at the transcriptional level through an forkhead response element on its promoter. Like FOXM1, NBS1 is overexpressed in the epirubicin-resistant MCF-7EpiR cells and its expression level is low but inducible by epirubicin in MCF-7 cells. Consistently, overexpression of FOXM1 augmented and FOXM1 depletion reduced NBS1 expression and epirubicin-induced ataxia-telangiectasia mutated (ATM)phosphorylation in breast cancer cells. Together these findings suggest that FOXM1 increases NBS1 expression and ATM phosphorylation, possibly through increasing the levels of the MRN(MRE11/RAD50/NBS1) complex. Consistent with this idea, the loss of P-ATM induction by epirubicin in the NBS1-deficient NBS1-LBI fibroblasts can be rescued by NBS1 reconstitution. Resembling FOXM1, NBS1 depletion also rendered MCF-7 and MCF-7EpiR cells more sensitive to epirubicin-induced cellular senescence. In agreement, the DNA repair-defective and senescence phenotypes in FOXM1-deficent cells can be effectively rescued by overexpression of NBS1. Moreover, overexpression of NBS1 and FOXM1 similarly enhanced and their depletion downregulated homologous recombination (HR) DNA repair activity. Crucially, overexpression of FOXM1 failed to augment HR activity in the background of NBS1 depletion, demonstrating that NBS1 is indispensable for the HR function of FOXM1. The physiological relevance of the regulation of NBS1 expression by FOXM1 is further underscored by the strong and significant correlation between nuclear FOXM1 and total NBS1 expression in breast cancer patient samples, further suggesting that NBS1 as a key FOXM1 target gene involved in DNA damage response, genotoxic drug resistance and DNA damage-induced senescence.
- 21 October 2013
- Published by Springer Nature in Oncogene
- Vol. 33 (32) , 4144-4155
Open AccessFOXM1 targets NBS1 to regulate DNA damage-induced senescence and epirubicin resistance
FOXM1 is implicated in genotoxic drug resistance but its mechanism of action remains elusive. We show here that FOXM1-depletion can sensitize breast cancer cells and mouse embryonic fibroblasts (MEFs) into entering epirubicin-induced senescence, with the loss of long-term cell proliferation ability, the accumulation of γH2AX foci, and the induction of senescence-associated β-galactosidase activity and cell morphology. Conversely, reconstitution of FOXM1 in FOXM1-deficient MEFs alleviates the accumulation of senescence-associated γH2AX foci. We also demonstrate that FOXM1 regulates NBS1 at the transcriptional level through an forkhead response element on its promoter. Like FOXM1, NBS1 is overexpressed in the epirubicin-resistant MCF-7EpiR cells and its expression level is low but inducible by epirubicin in MCF-7 cells. Consistently, overexpression of FOXM1 augmented and FOXM1 depletion reduced NBS1 expression and epirubicin-induced ataxia-telangiectasia mutated (ATM)phosphorylation in breast cancer cells. Together these findings suggest that FOXM1 increases NBS1 expression and ATM phosphorylation, possibly through increasing the levels of the MRN(MRE11/RAD50/NBS1) complex. Consistent with this idea, the loss of P-ATM induction by epirubicin in the NBS1-deficient NBS1-LBI fibroblasts can be rescued by NBS1 reconstitution. Resembling FOXM1, NBS1 depletion also rendered MCF-7 and MCF-7EpiR cells more sensitive to epirubicin-induced cellular senescence. In agreement, the DNA repair-defective and senescence phenotypes in FOXM1-deficent cells can be effectively rescued by overexpression of NBS1. Moreover, overexpression of NBS1 and FOXM1 similarly enhanced and their depletion downregulated homologous recombination (HR) DNA repair activity. Crucially, overexpression of FOXM1 failed to augment HR activity in the background of NBS1 depletion, demonstrating that NBS1 is indispensable for the HR function of FOXM1. The physiological relevance of the regulation of NBS1 expression by FOXM1 is further underscored by the strong and significant correlation between nuclear FOXM1 and total NBS1 expression in breast cancer patient samples, further suggesting that NBS1 as a key FOXM1 target gene involved in DNA damage response, genotoxic drug resistance and DNA damage-induced senescence.